The Winter 2019 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the world’s largest collection of…

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…

As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across…

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support We are excited to announce our acquisition N-of-One,…

With great networking opportunities, exciting panel discussions, and a packed exhibit hall, Precision Medicine World Conference 2019 was the place…

We’re launching our new Sample to Insight QIAact Myeloid DNA UMI Panel! We are unveiling our new Sample to Insight…

Fall is in full swing, and 2019 is fast approaching! Here’s a look at some of the top bioinformatics-adjacent stories…

AMP 2018 is almost here! We’re bringing our Sample to Insight solutions to San Antonio, Texas, November 1-3rd! Whether you’re…